400 Wood Rd.
Braintree, MA 02184
CEO: Brian Concannon
Stock Symbol: HAE
Haemonetics is a designer and manufacturer
of automated blood processing systems. These systems address
important medical markets: surgical blood salvage, blood component
collection, plasma collection, and blood component safety.
Haemonetics is organized around the end-users
of its products: blood donors and patients undergoing surgery.
Haemonetics was founded in 1971 to develop
an automated machine to separate blood into its component parts
-- plasma, platelets and red cells. It went public in 1979 and
was acquired by American Hospital Supply Corporation (AHS) in
1983. AHS itself was acquired in 1985 and divested the Haemonetics
line. Investors purchased Haemonetics and completed another public
offering in 1991.
Haemonetics has offices in 16 countries.
It markets products in over 50 countries.
For fiscal 2010, the company reported revenues of $645 million, up 8%, and net income of $58.3 million. Over half of the company's revenues are international.
Haemonetics offers medical, dental, vision
and life insurance.
Employees can contribute to a 401(k) plan
and Haemonetics will match 100% of the first 6% contributed.
This amount vests immediately.
Employee stock purchase is available at
a 15% discount.
The company offers 11 paid holidays and
up to 8 paid sick days for hourly employees. Hourly employees
can receive $50 for each sick day not used per year and a $130
bonus if no sick days are taken at all.
There is an on-site childcare center at